Piper Sandler Reiterates Overweight Rating on OrthoPediatrics, Sets $30 Target
Piper Sandler reiterated its Overweight rating and $30 price target on OrthoPediatrics. The target implies 25.9% upside from the Oct. 27 close of $23.82.
Story updates
04:02:46 PM UTC
SquawkNews
OrthoPediatrics Price Target Raised to $30.00/Share From $25.00 by Piper Sandler